Business Standard

India's first indigenous mRNA vaccine likely to be available soon

The Subject Expert Committee (SEC) has recommended granting the Emergency Use Authorisation (EUA) to the country's first mRNA-based Covid-19 vaccine in a meeting held on Friday

Gennova
Premium

Gennova's vaccine has an edge over its international peers as it does not require sub-zero temperatures like Pfizer-BioNTech and Moderna's vaccines

Sohini Das
Soon India may have its first indigenous mRNA vaccine that is stable at 2-8 degrees Celsius as the expert panel advising the Central Drugs Standards Control Organisation (CDSCO) has green-signalled Gennova Biopharma's mRNA vaccine candidate for Covid19.

The Subject Expert Committee (SEC) has recommended granting the Emergency Use Authorisation (EUA) to the country's first mRNA-based Covid-19 vaccine in a meeting held on Friday, according to reports.

Now, the Drugs Controller General of India (DCGI) will take a final call on granting the final approval.

The SEC has reviewed data from the trials done on 4000 volunteers.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 28 2022 | 10:46 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com